About Forvis Mazars
https://www.forvismazars.us/
Booth Staffs
More Organizations
Exact Sciences
Exact Sciences is now Abbott, bringing our leading portfolio of cancer screening and diagnostics tests to the most diversified company in health. Our solutions help patients and healthcare providers make timely, informed decisions before, during and after a cancer diagnosis. Our growing product line includes well-established brands such as Cologuard and Oncotype DX, along with innovative solutions like the Cancerguard test for multi-cancer early detection and the Oncodetect test for molecular residual disease and recurrence monitoring. We continue to invest in a robust pipeline of advanced diagnostics aimed at improving outcomes. For more information, visit ExactSciences.com.
GBS Corp.
GBS is an employee-owned organization founded in 1971 as a print management company and has remained profitable since inception. Over the past 50+ years, we have grown into a $275 million organization with approximately 325 employees, serving more than 30,000 clients nationwide. GBS holds a AAA Dun & Bradstreet rating and specializes in delivering innovative services that integrate and automate financial, technical and administrative operations across organizations. Our Healthcare Division, founded in Youngstown, Ohio, in the early 1980s, brings deep industry expertise combined with hardware and software capabilities to support clinical, financial, and administrative efficiency. We have a long-standing history as a top Value-Added Reseller for leading healthcare platforms including Versyss, PCN, McKesson, and NextGen®, and we partner with major technology providers such as HP, Dell, Lenovo, Microsoft, VMware, Cisco, and Fortinet. Our offerings are further strengthened by more than 30 years of experience in Revenue Cycle Management, Patient Identification, Hosting, and IT Managed Services. Our mission is to partner with world-class healthcare organizations to support their commitment to quality while delivering strong local support and value-added services.
Guardant Health
Guardant Health is a precision diagnostic oncology company focused on liquid biopsy testing across screening, treatment selection, and disease monitoring. Its Shield™ test is the first FDA-approved blood test for colorectal cancer screening, supported by Medicare, Medicaid, VA Community Care, and select commercial payers including UnitedHealthcare, and inclusion in NCCN and American Cancer Society guidelines. Shield offers providers and health systems a strategic option to expand screening access, close care gaps, and engage patients who remain unscreened despite the availability of existing methodologies.